Literature DB >> 25270716

WNT signaling in bone development and homeostasis.

Zhendong Zhong1, Nicole J Ethen, Bart O Williams.   

Abstract

The balance between bone formation and bone resorption controls postnatal bone homeostasis. Research over the last decade has provided a vast amount of evidence that WNT signaling plays a pivotal role in regulating this balance. Therefore, understanding how the WNT signaling pathway regulates skeletal development and homeostasis is of great value for human skeletal health and disease.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2014        PMID： 25270716      PMCID： PMC4199871          DOI： 10.1002/wdev.159

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Dev Biol        ISSN： 1759-7684            Impact factor:   5.814


  98 in total

Review 1.  A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.

Authors:  Michael T Veeman; Jeffrey D Axelrod; Randall T Moon
Journal:  Dev Cell       Date:  2003-09       Impact factor: 12.270

Review 2.  Parameters of LRP5 from a structural and molecular perspective.

Authors:  Mark L Johnson; Douglas T Summerfield
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2005       Impact factor: 1.807

3.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

4.  LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.

Authors:  Jitender Kumar; Maria Swanberg; Fiona McGuigan; Mattias Callreus; Paul Gerdhem; Kristina Akesson
Journal:  Bone       Date:  2011-05-27       Impact factor: 4.398

5.  The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless.

Authors:  F Rijsewijk; M Schuermann; E Wagenaar; P Parren; D Weigel; R Nusse
Journal:  Cell       Date:  1987-08-14       Impact factor: 41.582

6.  LRP6 mutation in a family with early coronary disease and metabolic risk factors.

Authors:  Arya Mani; Jayaram Radhakrishnan; He Wang; Alaleh Mani; Mohammad-Ali Mani; Carol Nelson-Williams; Khary S Carew; Shrikant Mane; Hossein Najmabadi; Dan Wu; Richard P Lifton
Journal:  Science       Date:  2007-03-02       Impact factor: 47.728

7.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

Review 8.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

9.  Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis.

Authors:  Chikara Kokubu; Ulrich Heinzmann; Tomoko Kokubu; Norio Sakai; Takuo Kubota; Masanobu Kawai; Matthias B Wahl; Juan Galceran; Rudolf Grosschedl; Keiichi Ozono; Kenji Imai
Journal:  Development       Date:  2004-10-06       Impact factor: 6.868

10.  Lrp5 functions in bone to regulate bone mass.

Authors:  Yajun Cui; Paul J Niziolek; Bryan T MacDonald; Cassandra R Zylstra; Natalia Alenina; Daniel R Robinson; Zhendong Zhong; Susann Matthes; Christina M Jacobsen; Ronald A Conlon; Robert Brommage; Qingyun Liu; Faika Mseeh; David R Powell; Qi M Yang; Brian Zambrowicz; Han Gerrits; Jan A Gossen; Xi He; Michael Bader; Bart O Williams; Matthew L Warman; Alexander G Robling
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440
View more
  43 in total

Review 1.  Wnt Antagonists in Hematopoietic and Immune Cell Fate: Implications for Osteoporosis Therapies.

Authors:  Betsabel Chicana; Cristine Donham; Alberto J Millan; Jennifer O Manilay
Journal:  Curr Osteoporos Rep       Date:  2019-04       Impact factor: 5.096

2.  Featured Article: Transcriptional landscape analysis identifies differently expressed genes involved in follicle-stimulating hormone induced postmenopausal osteoporosis.

Authors:  Katre Maasalu; Ott Laius; Lidiia Zhytnik; Sulev Kõks; Ele Prans; Ene Reimann; Aare Märtson
Journal:  Exp Biol Med (Maywood)       Date:  2016-11-20

Review 3.  Wnt signaling and cellular metabolism in osteoblasts.

Authors:  Courtney M Karner; Fanxin Long
Journal:  Cell Mol Life Sci       Date:  2016-11-26       Impact factor: 9.261

4.  Effects of oxidized low density lipoprotein on transformation of valvular myofibroblasts to osteoblast-like phenotype.

Authors:  Di Chen; Ying-Lian Shen; Wei-Lin Hu; Zheng-Ping Chen; Yong-Sheng Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

5.  Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy.

Authors:  Norine Voisin; Rhonda E Schnur; Sofia Douzgou; Susan M Hiatt; Cecilie F Rustad; Natasha J Brown; Dawn L Earl; Boris Keren; Olga Levchenko; Sinje Geuer; Sarah Verheyen; Diana Johnson; Yuri A Zarate; Miroslava Hančárová; David J Amor; E Martina Bebin; Jasmin Blatterer; Alfredo Brusco; Gerarda Cappuccio; Joel Charrow; Nicolas Chatron; Gregory M Cooper; Thomas Courtin; Elena Dadali; Julien Delafontaine; Ennio Del Giudice; Martine Doco; Ganka Douglas; Astrid Eisenkölbl; Tara Funari; Giuliana Giannuzzi; Ursula Gruber-Sedlmayr; Nicolas Guex; Delphine Heron; Øystein L Holla; Anna C E Hurst; Jane Juusola; David Kronn; Alexander Lavrov; Crystle Lee; Séverine Lorrain; Else Merckoll; Anna Mikhaleva; Jennifer Norman; Sylvain Pradervand; Darina Prchalová; Lindsay Rhodes; Victoria R Sanders; Zdeněk Sedláček; Heidelis A Seebacher; Elizabeth A Sellars; Fabio Sirchia; Toshiki Takenouchi; Akemi J Tanaka; Heidi Taska-Tench; Elin Tønne; Kristian Tveten; Giuseppina Vitiello; Markéta Vlčková; Tomoko Uehara; Caroline Nava; Binnaz Yalcin; Kenjiro Kosaki; Dian Donnai; Stefan Mundlos; Nicola Brunetti-Pierri; Wendy K Chung; Alexandre Reymond
Journal:  Am J Hum Genet       Date:  2021-05-06       Impact factor: 11.025

6.  The Wnt Antagonist SFRP1: A Key Regulator of Periodontal Mineral Homeostasis.

Authors:  Gokul Gopinathan; Deborah Foyle; Xianghong Luan; Thomas G H Diekwisch
Journal:  Stem Cells Dev       Date:  2019-07-22       Impact factor: 3.272

7.  Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.

Authors:  Elisabeth A Pedersen; Rajasree Menon; Kelly M Bailey; Dafydd G Thomas; Raelene A Van Noord; Jenny Tran; Hongwei Wang; Ping Ping Qu; Antje Hoering; Eric R Fearon; Rashmi Chugh; Elizabeth R Lawlor
Journal:  Cancer Res       Date:  2016-06-30       Impact factor: 12.701

8.  Wntless spatially regulates bone development through β-catenin-dependent and independent mechanisms.

Authors:  Zhendong A Zhong; Juraj Zahatnansky; John Snider; Emily Van Wieren; Cassandra R Diegel; Bart O Williams
Journal:  Dev Dyn       Date:  2015-08-21       Impact factor: 3.780

9.  Polycomb PRC2 complex mediates epigenetic silencing of a critical osteogenic master regulator in the hippocampus.

Authors:  Rodrigo Aguilar; Fernando J Bustos; Mauricio Saez; Adriana Rojas; Miguel L Allende; Andre J van Wijnen; Brigitte van Zundert; Martin Montecino
Journal:  Biochim Biophys Acta       Date:  2016-05-20

Review 10.  Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy.

Authors:  Antoine Boulanger Piette; Dounia Hamoudi; Laetitia Marcadet; Françoise Morin; Anteneh Argaw; Leanne Ward; Jérôme Frenette
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.